| DARE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DARE shares outstanding history going back to 7/20/2017:
Also see: DARE Market Cap History DARE YTD Return |
DARE Shares Outstanding History — Dare Bioscience Share Count Over Time
As of 5/13/2026 Dare Bioscience has 14.98 million DARE shares outstanding. Investors often track the DARE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DARE share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 7/20/2017.
| DARE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DARE Historical Shares Outstanding: +46.90% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DARE Stock Price Chart |
| About Dare Bioscience Inc |
| Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Co.'s U.S. Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1; DARE-VVA1; DARE-CIN; DARE-PDM1; DARE-204 and DARE-214, and DARE-FRT1 and DARE-PTB1. Its pre-clinical stage programs include DARE-LARC1, DARE-LBT, DARE-GML, DARE-RH1 and DARE-PTB2. We show 35 historical shares outstanding datapoints in our coverage of DARE's shares outstanding history. Understanding the changing numbers of DARE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DARE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DARE by allowing them to research DARE shares outstanding history as well as any other stock in our coverage universe. |
| DARE Current Stock Quote |
Quotes delayed 20 minutes  Free DARE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DARE Share Performance |
| Shares Outstanding Peers |
| Dare Bioscience (DARE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DAWN Shares Outstanding History DBTX Shares Outstanding History DCGO Shares Outstanding History DCOY Shares Outstanding History DCPH Shares Outstanding History DCTH Shares Outstanding History DEPO Shares Outstanding History DERM Shares Outstanding History DFFN Shares Outstanding History DFTX Shares Outstanding History More Healthcare companies » |
DARE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
